Cargando…

Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season

BACKGROUND: This study compared a rapid home-based up-dosing schedule for sublingual immunotherapy (SLIT) drops containing tree pollen allergens with two previously established schedules. Furthermore, the clinical effect of the SLIT was investigated with respect to patients’ first pollen season unde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mösges, Ralph, Breitrück, Nils Y., Allekotte, Silke, Shah-Hosseini, Kija, Dao, Van-Anh, Zieglmayer, Petra, Birkholz, Katrin, Hess, Mark, Bastl, Maximilian, Bastl, Katharina, Berger, Uwe, Kramer, Matthias F., Guethoff, Sonja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439405/ https://www.ncbi.nlm.nih.gov/pubmed/30937138 http://dx.doi.org/10.1016/j.waojou.2019.100012

Ejemplares similares

A meta‐analysis on allergen‐specific immunotherapy using MCT(®) (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis
por: Becker, Sven, et al.
Publicado: (2021)

P85 - Asthmatic children and adolescents treated in daily medical practice – results from a 2-year sublingual allergen immunotherapy (AIT) study with grass pollen tablets
por: Karagiannis, Efstrathios, et al.
Publicado: (2014)

Early nonreactivity in the conjunctival provocation test predicts beneficial outcome of sublingual immunotherapy
por: Köther, Janina, et al.
Publicado: (2018)

PD14 - Non-interventional 2-year study of sublingual immunotherapy in children and adolescents with allergic rhinoconjunctivitis caused by grass pollen
por: Karagiannis, Efstrathios, et al.
Publicado: (2014)

Defining Pollen Seasons: Background and Recommendations
por: Bastl, Katharina, et al.
Publicado: (2018)

Variability of grass pollen allergy symptoms throughout the season: Comparing symptom data profiles from the Patient's Hayfever Diary from 2014 to 2016 in Vienna (Austria)()
por: Bastl, Maximilian, et al.
Publicado: (2021)

A 12‐week DBPC dose‐finding study with sublingual monomeric allergoid tablets in house dust mite‐allergic patients
por: Hüser, C., et al.
Publicado: (2016)

The evaluation of pollen concentrations with statistical and computational methods on rooftop and on ground level in Vienna – How to include daily crowd-sourced symptom data
por: Bastl, Maximilian, et al.
Publicado: (2019)

Translating the Burden of Pollen Allergy Into Numbers Using Electronically Generated Symptom Data From the Patient’s Hayfever Diary in Austria and Germany: 10-Year Observational Study
por: Bastl, Katharina, et al.
Publicado: (2020)

Evaluation of Pollen Apps Forecasts: The Need for Quality Control in an eHealth Service
por: Bastl, Katharina, et al.
Publicado: (2017)

The influence of air pollution on pollen allergy sufferers
por: Berger, Markus, et al.
Publicado: (2021)

Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy
por: Moral, Angel, et al.
Publicado: (2016)

Nondaily dosing schedule of allergen-specific sublingual immunotherapy: efficacy and safety
por: Abdelwahab, Heba Wagih, et al.
Publicado: (2023)

A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio
por: Pfaar, Oliver, et al.
Publicado: (2023)

Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis
por: Jordakieva, Galateja, et al.
Publicado: (2017)

The connection of pollen concentrations and crowd-sourced symptom data: new insights from daily and seasonal symptom load index data from 2013 to 2017 in Vienna
por: Bastl, Katharina, et al.
Publicado: (2018)

Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis
por: Mösges, Ralph, et al.
Publicado: (2019)

Allergen immunotherapy phase II trials: Challenges in dose finding
por: Kleine-Tebbe, J., et al.
Publicado: (2019)

How to do a clinical trial? Recommendations from the aerobiological point of view
por: Bastl, Katharina, et al.
Publicado: (2019)

Allergen challenge tests in allergen immunotherapy: State of the art
por: Zieglmayer, Petra, et al.
Publicado: (2023)

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis
por: Devillier, Philippe, et al.
Publicado: (2014)

Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center
por: Lemberg, Marie-Luise, et al.
Publicado: (2017)

Management of Grass Pollen Allergy with 5-Grass Pollen Tablet: Results of a 2-Year Real-Life Study
por: Shah-Hosseini, Kija, et al.
Publicado: (2017)

Pollen calendars and maps of allergenic pollen in North America
por: Lo, Fiona, et al.
Publicado: (2019)

Specific IgE response to different grass pollen allergen components in children undergoing sublingual immunotherapy
por: Marcucci, Francesco, et al.
Publicado: (2012)

Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens
por: Fujii, Tatsuya, et al.
Publicado: (2022)

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
por: Gotoh, Minoru, et al.
Publicado: (2022)

Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy
por: Pfaar, O., et al.
Publicado: (2020)

First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients
por: Bergmann, Karl-Christian, et al.
Publicado: (2020)

Induction of Eosinophilic Esophagitis by Sublingual Pollen Immunotherapy
por: Miehlke, Stephan, et al.
Publicado: (2013)

Immunotherapy – 2074. Tolerability of sublingual immunotherapy with tropical mite allergen vaccines using different dosing schedules in asthmatic children
por: Almarales, Raúl Lázaro Castro, et al.
Publicado: (2013)

Variation in allergen content in sublingual allergen immunotherapy with house dust mites
por: Moreno Benítez, F., et al.
Publicado: (2015)

Long-term effects of allergen sublingual immunotherapy
por: Bozek, Andrzej, et al.
Publicado: (2019)

Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study
por: Worm, Margitta, et al.
Publicado: (2014)

No SARS-CoV-2 detected in air samples (pollen and particulate matter) in Leipzig during the first spread
por: Dunker, Susanne, et al.
Publicado: (2021)

Peanut Allergen Threshold Study (PATS): validation of eliciting doses using a novel single-dose challenge protocol
por: Zurzolo, Giovanni A, et al.
Publicado: (2013)

Relevant Patient Benefit of Sublingual Immunotherapy with Birch Pollen Allergen Extract in Allergic Rhinitis: An Open, Prospective, Non-Interventional Study
por: Blome, Christine, et al.
Publicado: (2020)

Poster 1000: Efficacy and safety of specific sublingual immunotherapy with carbamylated allergoid tablets of ragweed pollen: a dose-ranging study
por: Compalati, Enrico, et al.
Publicado: (2014)

Preparation of chemically stable allergen‐specific sublingual immunotherapy from Egyptian allergens
por: Abu El‐Enin, Mohammed A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tn5d7g59otqhuu09a7re37lk3c